Your browser doesn't support javascript.
loading
An update on pharmacotherapy for recurrent depression in 2022.
Belge, Jean-Baptiste; Sabbe, Amber C F; Sabbe, Bernard G C C.
Affiliation
  • Belge JB; Department of Psychiatry, Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
  • Sabbe ACF; Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Sabbe BGCC; Department of Internal Medicine, University Hospital of Antwerp, Edegem, Belgium.
Expert Opin Pharmacother ; 24(12): 1387-1394, 2023.
Article in En | MEDLINE | ID: mdl-37300545
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Expert Opin Pharmacother Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Expert Opin Pharmacother Journal subject: FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: